Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analyzing the impact of molecular testing on the cytological diagnosis of thyroid nodules: Insights from our institution's experience.

Cancer cytopathology·2025
Same author

Crystals and crystalloids in cytopathology: Incidence and importance.

Cancer cytopathology·2022
Same author

Performance of specific morphologic features in distinguishing low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions in borderline cases: a College of American Pathologists Cytopathology Committee multiobserver study.

Journal of the American Society of Cytopathology·2021
Same author

Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspiration.

Journal of thoracic disease·2019
Same author

CIC-DUX4 sarcoma diagnosed by fine-needle aspiration cytology: A case report.

Diagnostic cytopathology·2018
Same author

Low-Grade Squamous Intraepithelial Lesion or High-Grade Squamous Intraepithelial Lesion? Concordance Between the Interpretation of Low-Grade Squamous Intraepithelial Lesion and High-Grade Squamous Intraepithelial Lesion in Papanicolaou Tests: Results From the College of American Pathologists PAP Education Program.

Archives of pathology & laboratory medicine·2018
Same journal

Pleural Effusion Cytology of Metastatic Sclerosing Epithelioid Fibrosarcoma.

Diagnostic cytopathology·2026
Same journal

Turnaround Time Trends in Cervical Cytology Screening in South Africa, 2005-2023.

Diagnostic cytopathology·2026
Same journal

Spontaneous Infarction of Benign Salivary Gland Tumors: A Series of 5 Cases.

Diagnostic cytopathology·2026
Same journal

Atypical Carcinoid Tumor Metastatic to the Parotid Gland: A Case Report and Review of the Literature.

Diagnostic cytopathology·2026
Same journal

Case Report: Pancreatic Paraganglioma Mimicking a Well-Differentiated Neuroendocrine Tumor: The Importance of Cytokeratin Immunohistochemistry.

Diagnostic cytopathology·2026
Same journal

Diagnostic Value of CCL2 and CCR2 in Pleural Effusion for Distinguishing Lung Cancer Histological Subtypes: A Retrospective Study.

Diagnostic cytopathology·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Sarcoma redux: past, present, and future

Leslie G Dodd, Carlos W Bedrossian

    Diagnostic Cytopathology
    |August 29, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

    Published on: July 28, 2020

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
    08:07

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

    Published on: April 12, 2019

    Related Experiment Videos

    Last Updated: May 19, 2026

    The In ovo CAM-assay as a Xenograft Model for Sarcoma
    12:44

    The In ovo CAM-assay as a Xenograft Model for Sarcoma

    Published on: July 17, 2013

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

    Published on: July 28, 2020

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
    08:07

    Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

    Published on: April 12, 2019